Clinical Trials Directory

Trials / Completed

CompletedNCT01217216

Cancer Survival Through Weight Loss and Exercise

Cancer Survival Through Weight Loss and Exercise (CASTLE)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
52 (actual)
Sponsor
Pennington Biomedical Research Center · Academic / Other
Sex
Female
Age
30 Years – 75 Years
Healthy volunteers
Not accepted

Summary

To test the effectiveness and feasibility of intensive motivational, behavior modifying intervention aimed at improving physical activity and dietary habits to produce at least 7% weight loss in women with a history of breast cancer in a community health setting.

Detailed description

This study will be divided into two phases (Phase I and II) that will differ by the intensity of motivational intervention. In Phase I, participants will receive 6 months of intensive weekly group-based or telephone-based motivational, behavior modifying intervention aimed at improving physical activity levels and dietary habits. Phase II will be an additional 6 months of monthly individualized motivational intervention in order to attain and maintain at least 7% body weight loss. All participants will attend an orientation, 2 run-in sessions, and a baseline assessment prior to the intervention. Participants will then be assigned to either the group based intervention or telephone intervention. The first 30 participants will enter into the group-based intervention and the second 30 will enter into the telephone-based intervention. Follow-up visits will be completed at the end of Phase I (week 25) and Phase II (week 50). Up to 60 women with a previous history of breast cancer will participate in this study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALGroup-based Interventioncompared effects of a group-based intervention on weight loss and physical activity.
BEHAVIORALTelephone-based Interventioncompared telephone-based intervention to weight loss and physical activity.

Timeline

Start date
2009-05-01
Primary completion
2010-10-01
Completion
2010-10-01
First posted
2010-10-08
Last updated
2022-09-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01217216. Inclusion in this directory is not an endorsement.